Colorectal Cancer
S-1 active in advanced colorectal cancer
Published in Cancer Weekly, June 3rd, 2003
According to recent research from Belgium, "Cancer of the colon and rectum is one of the most frequent malignancies both in the U.S. and Europe.
"Standard palliative therapy is based on 5-fluorouracil/folinic acid combinations, with or without oxaliplatin or irinotecan, given intravenously.
"Oral medication has the advantage of greater patient convenience and acceptance and potential cost savings. S-1 is a new oral fluorinated pyrimidine derivative," wrote J. Van den Brande and colleagues, University Hospital Antwerp, Department of Medical Oncology.
"In a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-06-03)
More Articles from Cancer Weekly
- Ovarian Cancer
Tumor cell sensitivity - then resistance - to chemotherapy linked to gene - Pancreatic Cancer
Scientists uncover role of Fanconi anemia genes - Breast Cancer
Lower survival for black women under 50 may be due to differences in treatments - Cancer Therapy
Cell migration is the object of vascular targeting by combretastatin A-4 - Colon Cancer
High-calorie diet seems to increase chances of surviving longer - Prostate Cancer
Radioactive seed implantation safe and effective as alternative to surgery - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
